Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

HWU, WEN-JEN

One or more keywords matched the following items that are connected to HWU, WEN-JEN

Item Type	Name
Academic Article	Pelvic computed tomography scans for surveillance in patients with primary melanoma in the head and neck.
Academic Article	The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells.
Concept	Melanoma
Concept	Melanoma, Experimental
Academic Article	Multiple primary melanomas: data and significance.
Academic Article	A phase II study of interferon-alpha 2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanoma.
Academic Article	T-cell responses against tyrosinase 368-376(370D) peptide in HLA*A0201+ melanoma patients: randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants.
Academic Article	Temozolomide plus thalidomide in patients with advanced melanoma: results of a dose-finding trial.
Academic Article	Response of stage IV anal mucosal melanoma to chemotherapy.
Academic Article	Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma.
Academic Article	Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon a-2b in patients with resected high-risk melanoma.
Academic Article	Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects.
Academic Article	Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapy.
Academic Article	A phase II study of gefitinib in patients with metastatic melanoma.
Academic Article	Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma.
Academic Article	Comparison of two dosing schedules of palonosetron for the prevention of nausea and vomiting due to interleukin-2-based biochemotherapy.
Academic Article	Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.
Academic Article	Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.
Academic Article	Neuron-specific enolase as a tumor marker in metastatic melanoma.
Academic Article	Role of computed tomography in the staging of primary melanoma.
Academic Article	Prolonged survival in patients with advanced melanoma treated with neoadjuvant chemotherapy followed by resection.
Academic Article	The predictive value of lymphoscintigraphy for nodal metastases of cutaneous melanoma.
Academic Article	Staging work-up and post-treatment surveillance of patients with melanoma.
Academic Article	Treatment of metastatic melanoma in the brain with temozolomide and thalidomide.
Academic Article	Eruptive melanotic macules and papules associated with adenocarcinoma.
Academic Article	A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside.
Academic Article	Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.
Academic Article	A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
Academic Article	Prognostic factors for survival in melanoma patients with brain metastases.
Academic Article	Pharmacokinetics and safety of Marqibo (vincristine sulfate liposomes injection) in cancer patients with impaired liver function.
Academic Article	Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
Academic Article	Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma.
Academic Article	Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032).
Academic Article	Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.
Academic Article	Chemoprevention for brain metastases.
Academic Article	Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy.
Academic Article	PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging.
Academic Article	Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
Academic Article	BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma.
Academic Article	Chemical castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccination.
Academic Article	Immunomodulation and enhancement of antitumor activity by co-administration of 1,3-bis(2-chloroethyl)-1-nitrosourea and thymidine.
Academic Article	Colonic melanoma, primary or regressed primary.
Academic Article	Systemic chemotherapy.
Academic Article	Clinical results using biochemotherapy as a standard of care in advanced melanoma.
Academic Article	Diagnosis and management of stage I/II melanoma.
Academic Article	Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma.
Academic Article	Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens.
Academic Article	Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102).
Academic Article	The role of abdominoperineal resection as surgical therapy for anorectal melanoma.
Academic Article	Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
Academic Article	Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features.
Academic Article	Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma.
Academic Article	A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma.
Academic Article	Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma.
Academic Article	Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?
Academic Article	Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.
Academic Article	Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma.
Academic Article	Correlation between lipid-associated sialic acid and tumor burden in melanoma.
Academic Article	Safety and efficacy of isolated perfusion of extremities for recurrent tumor in elderly patients.
Academic Article	Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
Academic Article	Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.
Academic Article	Hypertrophic osteoarthropathy associated with metastatic melanoma.
Academic Article	Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.
Academic Article	Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients.
Academic Article	Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma.
Academic Article	Ipilimumab in the treatment of melanoma.
Academic Article	Changes in tumor morphology and cyclin-dependent kinase inhibitor expression in metastatic melanoma treated with selective second-generation BRAF inhibitor.
Academic Article	Regional isolated perfusion of extremities for melanoma: a 20-year experience with drugs other than L-phenylalanine mustard.
Academic Article	Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma.
Academic Article	Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21.
Academic Article	Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
Academic Article	Case of vemurafenib-induced Sweet's syndrome.
Academic Article	Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-a in patients with metastatic melanoma.
Academic Article	A phase I study of decitabine with pegylated interferon a-2b in advanced melanoma: impact on DNA methylation and lymphocyte populations.
Academic Article	Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
Academic Article	Ipilimumab in the treatment of advanced melanoma - a clinical update.
Academic Article	Treatment of BRAF-mutated advanced cutaneous melanoma.
Academic Article	Metastasis of ciliary body melanoma to the contralateral eye: a case report and review of uveal melanoma literature.
Academic Article	Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma.
Academic Article	Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma.
Academic Article	Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report.
Academic Article	Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab.
Academic Article	Treatment of BRAF-mutated advanced cutaneous melanoma
Academic Article	Programmed death-ligand 1 expression and response to the anti-programmed death 1 antibody pembrolizumab in melanoma
Academic Article	Immune Checkpoint Inhibitors for Treatment of Metastatic Melanoma of the Orbit and Ocular Adnexa
Academic Article	A phase I study of decitabine with pegylated interferon Î±-2b in advanced melanoma
Academic Article	Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with Pembrolizumab
Academic Article	Alternative temozolomide dosing regimens and novel combinations for the treatment of advanced metastatic melanoma
Academic Article	A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma
Academic Article	Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma
Academic Article	High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patients
Academic Article	Melanoma
Academic Article	Temozolomide plus pegylated interferon-Î±-2b in patients with metastatic melanoma
Academic Article	Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.
Academic Article	Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab.
Academic Article	Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.
Academic Article	Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
Academic Article	Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial.
Academic Article	Immune Checkpoint Inhibitors for Treatment of Metastatic Melanoma of the Orbit and Ocular Adnexa.
Academic Article	Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma.
Academic Article	Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade.
Academic Article	A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma.
Academic Article	High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patients.
Academic Article	A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.
Academic Article	Aberrant expression of FLI-1 in melanoma.
Academic Article	Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial.
Academic Article	The efficacy and safety of adjuvant interferon-alfa therapy in the evolving treatment landscape for resected high-risk melanoma.
Academic Article	Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program.
Academic Article	Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.
Academic Article	Desmoplastic Melanoma of the Periorbital Region.
Academic Article	High response rate to PD-1 blockade in desmoplastic melanomas.
Academic Article	Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma -- a clinical update.
Academic Article	Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2.
Academic Article	Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.
Academic Article	Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
Academic Article	Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma.
Academic Article	Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study.
Academic Article	Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Academic Article	Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver.
Academic Article	Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern.
Academic Article	Management of melanoma brain metastases.
Academic Article	Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study.
Academic Article	Correction: Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.
Academic Article	Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.
Academic Article	Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
Academic Article	A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma.
Academic Article	Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Academic Article	Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Academic Article	Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Academic Article	Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma.
Concept	gp100 Melanoma Antigen
Academic Article	Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
Academic Article	Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma.
Academic Article	Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma.
Academic Article	BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like Melanoma.
Academic Article	TERT amplification but not activation of canonical Wnt/?-catenin pathway is involved in acral lentiginous melanoma progression to metastasis.
Academic Article	Long-term Follow-up of Standard-Dose Pembrolizumab Plus Reduced-Dose Ipilimumab in Patients with Advanced Melanoma: KEYNOTE-029 Part 1B.
Academic Article	Prognostic significance of acral lentiginous histologic type in T1 melanoma.
Academic Article	Pathology-based Biomarkers Useful for Clinical Decisions in Melanoma.
Academic Article	Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma.
Academic Article	Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma.
Academic Article	Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma.
Academic Article	Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.

Search Criteria

Melanoma